A bench of Chief Justice J S Khehar and justices N V Ramana and D Y Chandrachud said the Centre should also submit the plan as how it intends to fill the large-scale vacancy at the ground level.
"You need people to successfully implement your policies at the ground level," the bench told the Centre.
Also Read
He said an online programme is being launched to detect the patients and their treatment.
Earlier, the apex court had asked the Centre and state governments to apprise it of steps taken to eradicate and curb leprosy, saying it was their responsibility to stop the spread of the disease which is curable.
The bench which was hearing a PIL filed by advocate Pankaj Sinha had earlier rapped the authorities for their "apathy" in eradicating leprosy from the country, saying despite it being "curable", the disease still remains a stigma.
Earlier too, the apex court had granted time for filing of replies by the Centre and others and had said, "This is a case which should have been taken on a priority basis. Leprosy, as on today, is curable and yet because of apathy shown by the authorities concerned, it still remains a stigma."
Sinha, in his plea, has alleged that leprosy affects over 1.25 lakh people annually in the country.
He had also alleged that governments have failed to eliminate the disease despite medical treatment available since 1981.
"Despite an effective cure, namely Multi-Drug Therapy (MDT) which has been available since 1981, that can completely cure 99 per cent of leprosy bacteria, due to apathy of the government of India and the state governments, people are still suffering from the said disease, which is treated as a social stigma," the petition said.
It has sought a direction to the governments that drugs be made available at primary health centres in the country.
It also pleaded that an appropriate scheme should be formulated to bring people suffering from leprosy into the national mainstream.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)